News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,252 Results
Type
Article (39496)
Company Profile (282)
Press Release (650474)
Section
Business (204082)
Career Advice (2012)
Deals (35411)
Drug Delivery (89)
Drug Development (80999)
Employer Resources (169)
FDA (16145)
Job Trends (14838)
News (345039)
Policy (32509)
Tag
Academia (2534)
Alliances (49292)
Alzheimer's disease (1293)
Approvals (16108)
Artificial intelligence (160)
Bankruptcy (354)
Best Places to Work (11607)
Biotechnology (199)
Breast cancer (204)
Cancer (1520)
Cardiovascular disease (120)
Career advice (1675)
Cell therapy (310)
Clinical research (64998)
Collaboration (564)
Compensation (307)
COVID-19 (2552)
C-suite (131)
Data (1465)
Diabetes (186)
Diagnostics (6197)
Earnings (85031)
Employer resources (147)
Events (110382)
Executive appointments (472)
FDA (16912)
Funding (509)
Gene therapy (216)
GLP-1 (620)
Government (4348)
Healthcare (18741)
Infectious disease (2649)
Inflammatory bowel disease (114)
Interviews (314)
IPO (16396)
Job creations (3641)
Job search strategy (1426)
Layoffs (428)
Legal (7891)
Lung cancer (223)
Manufacturing (214)
Medical device (13232)
Medtech (13237)
Mergers & acquisitions (19271)
Metabolic disorders (491)
Neuroscience (1654)
NextGen: Class of 2025 (6514)
Non-profit (4474)
Northern California (1858)
Obesity (280)
Opinion (190)
Parkinson's disease (106)
Patents (132)
People (56682)
Phase I (20216)
Phase II (28616)
Phase III (21353)
Pipeline (610)
Postmarket research (2566)
Preclinical (8560)
Radiopharmaceuticals (239)
Rare diseases (285)
Real estate (5901)
Regulatory (21811)
Research institute (2317)
Resumes & cover letters (350)
Southern California (1605)
Startups (3571)
United States (16530)
Vaccines (578)
Weight loss (195)
Date
Today (16)
Last 7 days (537)
Last 30 days (1830)
Last 365 days (34851)
2025 (1577)
2024 (35271)
2023 (40092)
2022 (51198)
2021 (55732)
2020 (54102)
2019 (46580)
2018 (35053)
2017 (32151)
2016 (31509)
2015 (37568)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (718)
Arizona (203)
Asia (37423)
Australia (6119)
California (4213)
Canada (1546)
China (358)
Colorado (189)
Connecticut (203)
Europe (80142)
Florida (596)
Georgia (146)
Illinois (413)
Indiana (239)
Maryland (679)
Massachusetts (3260)
Michigan (182)
Minnesota (314)
New Jersey (1178)
New York (1197)
North Carolina (779)
Northern California (1858)
Ohio (152)
Pennsylvania (994)
South America (1096)
Southern California (1605)
Texas (610)
Utah (119)
Washington State (427)
690,252 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Genentech to Lay Off 93 in San Francisco
Genentech’s latest layoffs are the second round of workforce reductions this year, following the company’s announcement in April that it was letting go around 3% of employees.
August 28, 2024
·
1 min read
·
Angela Gabriel
Business
Genentech Shutters Cancer Immunology Group Amid Wider R&D Reprioritization
The unit’s closure comes as Genentech’s parent Roche rethinks its cancer business, an effort that has included the discontinuation of three early-stage candidates and a T-cell partnership with Adaptimmune.
August 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease
December 19, 2024
·
5 min read
Press Releases
Five-Year Results Confirm Genentech’s Polivy Combination Therapy as New Standard of Care for Previously Untreated Aggressive Lymphoma
December 9, 2024
·
19 min read
Press Releases
New and Updated Data for Genentech’s Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their Potential to Improve Outcomes for People With Lymphoma
December 9, 2024
·
19 min read
Press Releases
FDA Accepts Supplemental Biologics License Application for Genentech’s Columvi Combination for People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
December 5, 2024
·
16 min read
Deals
Cash-Strapped Sangamo Gets Lifeline from Genentech in Potential $1.9B Neuro Deal
Sangamo Therapeutics announced Tuesday it secured an exclusive licensing agreement with Roche’s Genentech, which is paying $50 million in near-term upfront fees and milestone payments to develop novel genomic medicines for neurodegenerative diseases.
August 6, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Genentech Reports Update on Phase III SKYSCRAPER-01 Study Results
November 26, 2024
·
8 min read
Policy
FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s New Drug Application and granted Priority Review to inavolisib, an investigational oral therapy, in combination with palbociclib and fulvestrant.
May 29, 2024
·
6 min read
Biotech Bay
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk
Genentech, a member of the Roche Group, announced new 5-year data confirming the sustained efficacy and safety profile of Evrysdi® in children with Type 1 spinal muscular atrophy from the open-label extension of the pivotal FIREFISH study.
June 7, 2024
·
9 min read
1 of 69,026
Next
